4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) insider Scott Bizily sold 1,635 shares of the stock in a transaction on Friday, October 16th. The stock was sold at an average price of $12.84, for a total transaction of $20,993.40. Following the sale, the insider owned 8,617 shares of the company’s stock, valued at […]

City Therapeutics, Inc. (NASDAQ:CTY – Get Free Report) Director Robert Nelsen purchased 170,000 shares of the firm’s stock in a transaction on Monday, October 19th. The stock was bought at an average price of $18.00 per share, with a total value of $3,060,000.00. Following the acquisition, the director owned 13,692,507 shares in the company, valued […]

Maplight Therapeutics, Inc. (NASDAQ:MPLT – Get Free Report) CEO Christopher Kroeger sold 73,691 shares of the firm’s stock in a transaction that occurred on Thursday, October 15th. The stock was sold at an average price of $8.08, for a total transaction of $595,423.28. Following the sale, the chief executive officer directly owned 1,195,909 shares of […]

Ocular Therapeutix, Inc. (NASDAQ:OCUL – Get Free Report) insider Todd Anderman sold 11,984 shares of the stock in a transaction that occurred on Thursday, October 8th. The stock was sold at an average price of $7.29, for a total value of $87,363.36. Following the completion of the transaction, the insider directly owned 140,484 shares of […]

Palvella Therapeutics, Inc. (NASDAQ:PVLA – Get Free Report) Director George Jenkins sold 13,152 shares of Palvella Therapeutics stock in a transaction dated Monday, October 12th. The shares were sold at an average price of $133.69, for a total transaction of $1,758,290.88. Following the transaction, the director directly owned 146,964 shares of the company’s stock, valued […]

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) VP Mark Boulding sold 1,638 shares of the business’s stock in a transaction on Monday, October 5th. The stock was sold at an average price of $64.03, for a total transaction of $104,881.14. Following the completion of the transaction, the vice president directly owned 105,272 shares in […]